|Issuer:||ALLOVIR, INC. (ALVR)|
|Original Submission Date:|
C/O ALLOVIR, INC.
139 MAIN STREET, SUITE 500 CAMBRIDGE, MA 02142
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||21.51||2021-05-25||deemed execution date||A||22,500 (a)||2031-05-24||common stock 22,500||$21.51||22,500||direct|
|f1||this option shall vest and become exercisable upon the earlier to occur of (i) may 25, 2022 and (ii) the next annual meeting of the issuer's stockholders.|